Skip to main content
. 2022 Mar 15;12:770628. doi: 10.3389/fonc.2022.770628

Figure 2.

Figure 2

NCAPG is highly expressed in glioma tissues and could be a biomarker for glioma. (A) NCAPG is highly expressed in glioma tissue compared with normal tissue. (B) The expression of NCAPG in high-grade glioma tissues (GBM) and low-grade glioma tissues (LGG) analyzed by GEPIA. (C) Significantly enriched pathways associated with NCAPG by gene set enrichment analysis (GSEA). (D, E) Survival curve of NCAPG expression in TCGA and CGGA, respectively. (F, G) Differential expression of NCAPG in different cancer grades and isocitrate dehydrogenase (IDH) mutations. (*P < 0.05, ***P < 0.001).